OR WAIT null SECS
November 02, 2016
The proliferation of counterfeit medicines is nothing new to pharma; however, the scale of the problem seems to be escalating.
October 05, 2016
Value assessment initiatives are expected to have a major impact on drug use and reimbursement.
October 02, 2016
Susan Schniepp, distinguished fellow at Regulatory Compliance Associates, discusses the assessment of risk in the processing of intravenous injectable drugs.
The editors seek drug development experts to contribute technical articles for 2017.
September 12, 2016
Following the United Kingdom’s decision to leave the European Union, there are two areas that demand attention-clinical trials and marketing authorization
September 02, 2016
Pricing of a lifesaving allergy treatment raises concerns.
August 24, 2016
Steep price increases for a popular drug have created patient and Congressional backlash.
August 01, 2016
Congressional partisanship creates noise, but no funding for Zika virus research.
July 02, 2016
Siegfried Schmitt, Principal Consultant, PAREXEL International, discusses standard operating procedures for the regulatory affairs department.
CPhI Pharma Awards seek nominations for excellence in development and manufacturing.